| Product Code: ETC9947515 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the United Kingdom legalized cannabis medical market, the import trend saw a growth rate of 0.67% from 2023 to 2024, with a compound annual growth rate (CAGR) of 2.33% from 2020 to 2024. This slight increase in import momentum could be attributed to evolving regulations or shifts in global supply dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Legalized Cannabis Medical Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, 2022 & 2032F |
3.3 United Kingdom (UK) Legalized Cannabis Medical Market - Industry Life Cycle |
3.4 United Kingdom (UK) Legalized Cannabis Medical Market - Porter's Five Forces |
3.5 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.7 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume Share, By End Use, 2022 & 2032F |
3.8 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume Share, By Compound, 2022 & 2032F |
4 United Kingdom (UK) Legalized Cannabis Medical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing acceptance of medical cannabis for treating various health conditions |
4.2.2 Increasing awareness about the potential benefits of medical cannabis |
4.2.3 Favorable regulatory environment supporting the legalization of medical cannabis in the UK |
4.3 Market Restraints |
4.3.1 Lack of standardized regulations and guidelines for medical cannabis usage |
4.3.2 Limited availability of medical cannabis products and dispensaries |
4.3.3 Concerns about misuse and abuse of medical cannabis leading to stricter regulations |
5 United Kingdom (UK) Legalized Cannabis Medical Market Trends |
6 United Kingdom (UK) Legalized Cannabis Medical Market, By Types |
6.1 United Kingdom (UK) Legalized Cannabis Medical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By Product Type, 2022-2032F |
6.1.3 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Herb, 2022-2032F |
6.1.4 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Resin, 2022-2032F |
6.2 United Kingdom (UK) Legalized Cannabis Medical Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By Raw, 2022-2032F |
6.2.3 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By Processed, 2022-2032F |
6.3 United Kingdom (UK) Legalized Cannabis Medical Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By Recreational, 2022-2032F |
6.3.3 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By Medicinal, 2022-2032F |
6.4 United Kingdom (UK) Legalized Cannabis Medical Market, By Compound |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By THC-Dominant, 2022-2032F |
6.4.3 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By CBD-Dominant, 2022-2032F |
6.4.4 United Kingdom (UK) Legalized Cannabis Medical Market Revenues & Volume, By Balanced THC & CBD, 2022-2032F |
7 United Kingdom (UK) Legalized Cannabis Medical Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Legalized Cannabis Medical Market Export to Major Countries |
7.2 United Kingdom (UK) Legalized Cannabis Medical Market Imports from Major Countries |
8 United Kingdom (UK) Legalized Cannabis Medical Market Key Performance Indicators |
8.1 Number of medical professionals prescribing medical cannabis |
8.2 Patient satisfaction and reported health improvements |
8.3 Research and development investments in new medical cannabis products |
8.4 Number of approved medical cannabis licenses for cultivation and distribution |
8.5 Adoption rates of medical cannabis treatments by different healthcare facilities |
9 United Kingdom (UK) Legalized Cannabis Medical Market - Opportunity Assessment |
9.1 United Kingdom (UK) Legalized Cannabis Medical Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 United Kingdom (UK) Legalized Cannabis Medical Market Opportunity Assessment, By Form, 2022 & 2032F |
9.3 United Kingdom (UK) Legalized Cannabis Medical Market Opportunity Assessment, By End Use, 2022 & 2032F |
9.4 United Kingdom (UK) Legalized Cannabis Medical Market Opportunity Assessment, By Compound, 2022 & 2032F |
10 United Kingdom (UK) Legalized Cannabis Medical Market - Competitive Landscape |
10.1 United Kingdom (UK) Legalized Cannabis Medical Market Revenue Share, By Companies, 2025 |
10.2 United Kingdom (UK) Legalized Cannabis Medical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here